.JPG?#)
Bristol Myers Q1 earnings: Transition continues as drugmaker raises guidance
Bristol Myers Squibb’s evolution after sweeping cost-cutting measures kept chugging along as the company reported first-quarter earnings Thursday morning. While overall revenue declined by 6% to $11.2 billion, compared with the first quarter of 2024 ...
Bristol Myers Squibb’s evolution after sweeping cost-cutting measures kept chugging along as the company reported first-quarter earnings Thursday morning.
While overall revenue declined by 6% to $11.2 billion, compared with the first quarter of 2024 ...
